Boost Pharma Aps announced that it will receive equity funding on May 28, 2024.

On the same date, the company received its first tranche. The transaction included participation from new investors Industrifonden and Karolinska Development AB (publ), which includes a second tranche later this year, will amount to 10% stake in the company.